SGS Union Research Center, a Division of SGS North America, Inc.
Union City, New Jersey, 07083, United States
NCT Number: NCT06654102
The objective of this study is to assess the level of pigmentation following an acute exposure of skin to light regimens representative of portions of the natural sunlight spectrum and that contain Deep UVA wavelengths with or without HEV Blue Light, as compared to non-irradiated control skin.
Looking for future studies?
Notify Me18 year–60 year
Female
Interventional
Not applicable
Union City, New Jersey, 07083, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A timed series of 6 UV doses will be administered to subsites 2 to 7 within Test Site 1 and 2 using an accurately calibrated solar simulator by varying the irradiation intensity for each subsite and keeping the duration of irradiation constant for all subsites. The duration of irradiation for each test site will be 30 minutes.
A timed series of 6 UV doses will be administered to subsites 2 to 7 within Test Site 3 and 4 using an accurately calibrated solar simulator by varying the irradiation intensity for each subsite and keeping the duration of irradiation constant for all subsites. The duration of irradiation for each test site will be 30 minutes.
Time frame: 15 mins and 18-22 hours Post-Irradiation
The subsites of each test site will be graded for immediate or persistent pigmentation darkening (IPD/PPD) by a trained evaluator using a 0-2 grading scale, where 0 = no pigmentation darkening and 2 = moderate to intense pigmentation darkening.The mean values will be compared between each irradiated subsite and the non-irradiated subsite within the same test site and between each subsite in Regimen 1 compared to its corresponding subsite in Regimen 2.
Time frame: Baseline, 15 mins and 18-22 hours Post-Irradiation
Images of each test site will be analyzed to quantify the level of pigmentation using L* and b* color space values, where an increase in pigmentation corresponds to a decrease in L* values and a potential decrease in b* values or increase in a* values. Change from baseline will be calculated. The mean values will be compared between each irradiated subsite and the non-irradiated subsite within the same test site and between each subsite in Regimen 1 compared to its corresponding subsite in Regimen 2.
Time frame: Baseline, 15 mins and 18-22 hours Post-Irradiation
A Chromameter will be used to quantify the level of pigmentation of subsites 1 and 7 using L* and b* color space values, where an increase in pigmentation corresponds to a decrease in L* values and a potential decrease in b* values or increase in a* values. Change from baseline will be calculated. The mean values will be compared between each irradiated subsite and the non-irradiated subsite within the same test site and between each subsite in Regimen 1 compared to its corresponding subsite in Regimen 2.
Johnson & Johnson Consumer Inc. (J&JCI)
Industry
A Controlled, Single Center Study to Evaluate the Cutaneous Effects of Deep Ultraviolet A (UVA) +/- High-Energy Visible (HEV) Blue Light Exposure
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07537595
Healthy Volunteers, Hyperpigmentation
Bucharest, Romania
View Trial DetailsNCT05311033
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Nice, Alpes-maritimes, France
View Trial DetailsNCT06384092
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Gandhinagar, Gujarat, India
View Trial DetailsNCT04270903
Free Radicals, Magnetic Resonance
Brussels, Belgium
View Trial Details